Abdelmalik Slassi
Direttore/Membro del Consiglio presso PHARMALA BIOTECH HOLDINGS INC.
Patrimonio netto: 1 M $ in data 31/10/2023
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Nick Kadysh | M | 38 |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | 4 anni |
| Jodi Butts | F | 51 |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | 3 anni |
| Perry Tsergas | M | 39 |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | 3 anni |
| Fraser MacDonald | M | 38 |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | 3 anni |
| Kevin Roy | M | - | 2 anni | |
| Carmelo Marrelli | M | 53 | 3 anni | |
| Shane Morris | M | 49 |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | 3 anni |
| Harriet de Wit | M | 76 |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | 3 anni |
| Kathleen Large | F | 64 | 5 anni | |
| Harpreet Kaur | F | - | - | |
| David Purcell | M | - | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Niclas Stiernholm | M | - | 8 anni | |
| Jan Skvarka | M | 57 | 2 anni | |
| Helena Tayton-Martin | M | 57 | 4 anni | |
| Solomon Elimimian | M | 38 | 1 anni | |
| Eric Sievers | M | 60 | 3 anni | |
| Yaping Shou | M | - | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 12 | 70.59% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Abdelmalik Slassi
- Contatti personali
